Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Prepaid Assets (2016 - 2025)

Traws Pharma (TRAW) has disclosed Prepaid Assets for 14 consecutive years, with $332000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets changed N/A to $332000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $332000.0, a N/A change, with the full-year FY2024 number at $1.8 million, up 360.85% from a year prior.
  • Prepaid Assets was $332000.0 for Q3 2025 at Traws Pharma, down from $966000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q4 2024 to a low of $149000.0 in Q1 2025.
  • A 5-year average of $516250.0 and a median of $366500.0 in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: decreased 24.51% in 2022, then soared 427.87% in 2025.
  • Traws Pharma's Prepaid Assets stood at $253000.0 in 2021, then dropped by 24.51% to $191000.0 in 2022, then skyrocketed by 109.95% to $401000.0 in 2023, then surged by 360.85% to $1.8 million in 2024, then plummeted by 82.03% to $332000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Prepaid Assets are $332000.0 (Q3 2025), $966000.0 (Q2 2025), and $149000.0 (Q1 2025).